Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
7.06
+0.05 (0.71%)
At close: Sep 18, 2026, 4:00 PM EDT
6.86
-0.20 (-2.83%)
After-hours: Sep 18, 2026, 7:18 PM EDT
Quoin Pharmaceuticals Employees
As of December 31, 2025, Quoin Pharmaceuticals had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$3,110,886
Market Cap
33.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 1 | 20.00% | 4 | 2 |
| Dec 31, 2024 | 5 | 1 | 25.00% | 3 | 2 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Aligos Therapeutics | 82 |
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Actinium Pharmaceuticals | 27 |
| Filana Therapeutics | 20 |
| ABVC BioPharma | 19 |
| BriaCell Therapeutics | 16 |
QNRX News
- 1 day ago - Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders - TheFly
- 1 day ago - Quoin Pharmaceuticals Registration statement: Registration filing - Filings
- 9 days ago - Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU - GlobeNewsWire
- 11 days ago - CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - GlobeNewsWire
- 11 days ago - Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003 - TheFly
- 11 days ago - Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - GlobeNewsWire
- 22 days ago - Quoin Pharmaceuticals announces $50M private placement - TheFly
- 22 days ago - Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003 - TheFly